Taperloc Complete Microplasty Stem
510(k) K110400
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK110400 | Date30 Sep 2011 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KWA
- Device Class
- Class III
- Regulation
- 21 CFR Part 888.3330
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Taperloc Complete Microplasty Stem is a semi-constrained, uncemented acetabular component designed for hip arthroplasty. It is a porous-coated femoral stem intended for biological fixation in cementless hip replacements, providing stability and integration with the femoral bone.
This device is supplied in multiple sizes and offsets, including standard and shortened Microplasty stem lengths. It is classified as a Class III medical device under FDA regulations (K110400, KWA) and is intended for use in orthopedic surgical settings. The device is not described as sterile or single-use in the provided data, and no MRI safety information is specified.
Other devices from Biomet Manufacturing Corp
Questions
AI-generated answers, 18 Sep 2026
What types of hip replacements is the Taperloc Complete Microplasty Stem designed for, and how does it differ from other acetabular components?
The Taperloc Complete Microplasty Stem is specifically designed for cementless hip arthroplasty, focusing on biological fixation with the femoral bone. It is a semi-constrained, uncemented acetabular component with a porous-coated femoral stem, which promotes integration and stability without the need for bone cement. This distinguishes it from cemented stems or fully constrained designs, as it relies on osseointegration for long-term stability.
Are there different sizes or offsets available for this device, and how might that affect my surgical planning?
Yes, the Taperloc Complete Microplasty Stem is supplied in multiple sizes and offsets, including standard and shortened Microplasty stem lengths. This variability allows surgeons to select the appropriate fit for the patient’s anatomy, ensuring proper alignment and stability during hip replacement. The shortened lengths may be particularly useful for patients with limited femoral bone stock or specific anatomical constraints.
Is the Taperloc Complete Microplasty Stem intended for single-use or can it be reused in a clinical setting?
The provided data does not explicitly state whether the Taperloc Complete Microplasty Stem is sterile or intended for single-use. However, as it is a porous-coated, uncemented implant, it is typically designed for single-patient use to maintain sterility and reduce infection risks. Reuse would require strict reprocessing protocols, which are not mentioned in the documentation, so it is safest to assume it is intended for single-use.
What regulatory pathway was followed for this device, and what does that mean for its use in clinical practice?
The Taperloc Complete Microplasty Stem was cleared through the FDA 510(k) pathway, specifically under Traditional Review by the Orthopedic (OR) Advisory Committee. It was determined to be substantially equivalent to a legally marketed predicate device, meaning it meets FDA standards for safety and effectiveness as a Class III medical device for orthopedic use. This clearance allows it to be legally marketed and used in U.S. clinical settings for hip arthroplasty procedures.